Target intelligence / Profile preview

Collagen and elastin synthesis

Molecular classification
Other
01

Overview

Collagen and elastin synthesis is a fundamental process occurring primarily in **fibroblasts** of connective tissue, responsible for producing the proteins collagen (which provides tensile strength) and elastin (which confers elasticity)[2][4][5][6]. Collagen synthesis involves translation of alpha chains, post-translational modification (hydroxylation, glycosylation), triple-helix assembly, secretion, and extracellular crosslinking[1][3]. Elastin is produced as tropoelastin, which aggregates and is crosslinked extracellularly, forming elastic fibers able to stretch and recoil[4][5]. Disruption of these processes underlies skin aging, fibrotic diseases, certain genetic syndromes, and impacts other tissue systems, such as cardiovascular and pulmonary tissues. The synthesis of both proteins is highly regulated and involves key enzymes (e.g., lysyl oxidase, prolyl hydroxylase) and cofactors (notably vitamin C), and their breakdown is mediated by matrix metalloproteinases[1][3][6]. Drugs and supplements may affect these pathways, but "collagen and elastin synthesis" itself is not a specific target; rather, individual enzymes, receptors, or pathways involved in the regulation may serve as true therapeutic targets.

Other names
Collagen synthesiselastin synthesisbiosynthesis of collagen and elastin
02

Mechanism of action

Upregulation of fibroblast gene expression for ECM proteins; Enzyme cofactor provision (e.g., vitamin C for hydroxylation); Growth factor modulation (e.g., TGFβ signaling)

03

Biological functions

Tissue strength and elasticityExtracellular matrix formationCell adhesion and migrationWound healing
04

Disease associations

Aging (skin wrinkling and loss of elasticity)Fibrosis (excessive collagen deposition)Connective tissue disorders (e.g., Ehlers–Danlos syndrome, supravalvular aortic stenosis)Cancer (tumor microenvironment remodeling)Cardiovascular disease (arterial stiffness)
05

Safety considerations

Fibrosis risk with excessive collagen synthesisAllergy/reaction risk to collagen/peptide supplementsTumor progression in pathologic ECM remodelingVascular stiffness with abnormal elastin turnover
06

Interacting drugs

Retinoids (stimulate collagen synthesis)

4 more in the full profile.

07

Biomarkers

Procollagen type I C-peptide (for collagen synthesis rate)Elastin-derived peptides (for elastin turnover)Matrix metalloproteinase levels (MMP-1, MMP-3, MMP-12 for breakdown)

Beyond the preview

Go deeper on Collagen and elastin synthesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen and elastin synthesis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call